The formulation and stability of erythromycin-benzoyl peroxide in a topical gel

International Journal of Pharmaceutics

Volumn 178, Issue 1, 1999, Pages 137-141

  Vermeulen, B ^a   Remon, J P ^a   Nelis, H ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Benzoyl peroxide; Erythromycin; Formulation; Gel

Indexed keywords

BENZAMYCIN; BENZOYL PEROXIDE; CARBOPOL 940; ERYTHROMYCIN; HYDROXYETHYLCELLULOSE; UNCLASSIFIED DRUG;

ARTICLE; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; BENZOYL PEROXIDE; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INTERACTIONS; DRUG STABILITY; ERYTHROMYCIN; EXCIPIENTS; GELS; KERATOLYTIC AGENTS; MICROBIOLOGICAL TECHNIQUES; POLYVINYLS; PRECIPITATION; TEMPERATURE;

EID: 0032972862     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00366-4     Document Type: Article

References (6)

1. Arret B., Johnson D.P., Kirshbaum A. Outline of details for microbiological assays of antibiotics: second revision. J. Pharm. Sci. 60(11):1971;1689-1694.
2. British Pharmacopoeia, 1988 Her Majesty's Stationery Office, London, A146-A152.
3. Chalker D.K., Shalita A.R., Smith J.G., Swann R.W. A double-blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris. J. Am. Acad. Dermatol. 9:1983;933-936.
4. Eady E.A., Farmery M.R., Ross J.I., Cove J.H., Cunliffe W.J. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic sensitive and -resistant skin bacteria from acne patients. Br. J. Dermatol. 131:1994;331-336.
5. Harkaway K.S., Mc Ginley K.J., Foglia A.N. et al. Antibiotics resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide and combination therapy. Br. J. Dermatol. 126:1992;586-590.
6. Vandenbossche G.M.R., Vanhaecke E., De Muynck C., Remon J.P. Stability of topical erythromycin formulations. Int. J. Pharm. 67:1991;195-199.